KUALA LUMPUR: G3 Global Bhd
has secured approval from its shareholders to venture into the higher-margin healthcare business, beginning with the sale of Covid-19 test kits.
In a statement, the artificial intelligence (AI) specialist said its shareholders at an EGM also approved a cash call to grow the healthcare and ICT divisions; a higher limit to issue new shares; and the engagement in related party transactions (RPT).
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
